XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net cash provided by operating activities $ (27,081) $ 61,265
Cash flows from investing activities:    
Proceeds from sale of property and equipment 1 16
Purchases of property and equipment (2,185) (1,211)
Purchases of equity securities (29,333) (8,175)
Purchases of available-for-sale debt securities (57,163) (178,828)
Proceeds from sales of equity securities 14,932 1,576
Proceeds from sales of available-for-sale debt securities 12,540 27,455
Proceeds from sales of investment real estate 0 2,591
Maturities of available-for-sale debt securities 12,766 25,178
Net cash provided by (used in) investing activities (48,442) (131,398)
Cash flows from financing activities:    
Debt issuance costs paid (100) 0
Preferred stock dividend (3) (3)
Common stock dividend (5,029) (5,083)
Purchase of treasury stock (3,879) (245)
Payments related to tax withholding for share-based compensation (209) (495)
Repayment of debt (367) (368)
Net cash provided by (used in) financing activities (9,587) (6,194)
Cash and cash equivalents and restricted cash and cash equivalents:    
Net increase (decrease) during the period (85,110) (76,327)
Balance, beginning of period 253,143 179,871
Balance, end of period 168,033 103,544
Cash and cash equivalents, and restricted cash and cash equivalents within the Consolidated Balance Sheets    
Cash and cash equivalents 165,398  
Restricted cash and cash equivalents [1] 2,635  
Total cash and cash equivalents and restricted cash and cash equivalents $ 168,033 $ 103,544
[1] See “—Note 5 (Insurance Operations)” for a discussion of the nature of the restrictions for restricted cash and cash equivalents.